Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.

about

Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.

Item

http://www.wikidata.org/entity/Q50527728

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Association between SCAP and S ...... with atypical antipsychotics.

@en

Association between SCAP and S ...... with atypical antipsychotics.

@nl

type

Item

label

Association between SCAP and S ...... with atypical antipsychotics.

@en

Association between SCAP and S ...... with atypical antipsychotics.

@nl

prefLabel

Association between SCAP and S ...... with atypical antipsychotics.

@en

Association between SCAP and S ...... with atypical antipsychotics.

@nl

P1476

Association between SCAP and S ...... with atypical antipsychotics.

@en

P2093

Jianhua Chen

http://www.w3.org/2001/XMLSchema#string

Lin Yang

http://www.w3.org/2001/XMLSchema#string

Shenxun Shi

http://www.w3.org/2001/XMLSchema#string

Shiqiao Liang

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

Yifeng Xu

http://www.w3.org/2001/XMLSchema#string

Yongyong Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Haploview: analysis and visualization of LD and haplotype maps

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

Systematic identification of trans eQTLs as putative drivers of known disease associations

The metabolic syndrome--a new worldwide definition

Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs.

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

A mathematical model of the sterol regulatory element binding protein 2 cholesterol biosynthesis pathway.

Overexpression of membrane domain of SCAP prevents sterols from inhibiting SCAP.SREBP exit from endoplasmic reticulum.

Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin.

Regulation of gene expression by SREBP and SCAP.

P304

467-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/15622975.2016.1165865

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26982812

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

metabolic syndrome